RxDoctor Payments Data
★ My doctorsLook up a doctor →

Bradley Cohen

Hematology · Nyack, NYNPI 1801839113

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,060 of the $8,969 with a category attached, or 89.9%. It is spread thinly across 60 manufacturers, the largest accounting for just 9.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,551 and has fallen 98.4% since, to $56 in 2024.

$8,969in general payments, 2019–2025

Across 499 payments — averaging $17.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$873
  • Johnson & Johnson$820
  • AstraZeneca$649
  • Novartis$571
  • Pfizer$554
  • Merck$483
  • plus $5K from 54 others
$232,708in research payments, 2019–2025

Across 13 payments — averaging $17,901 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$203K
  • Pfizer$17K
  • UCB SA$13K

What the payments were for

  • Food & beverage$8,06090%
  • Education$90810%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen43$873
Johnson & Johnson(2 entities)42$820
AstraZeneca(2 entities)33$649
Novartis36$571
Pfizer44$554
Merck34$483
E.r. Squibb & Sons, L.L.C.29$422
Gilead(2 entities)17$264
Incyte Corporation13$261
Pharmacyclics LLC, An Abbvie Company12$250
Seagen Inc.12$234
Lilly USA, LLC9$233
Eisai Inc.12$232
Exelixis Inc.7$197
Genentech USA, Inc.13$182
Astellas Pharma US Inc5$160
Sanofi8$160
Bayer9$150
Daiichi Sankyo Inc.7$134
Jazz Pharmaceuticals Inc.5$118
Biogen6$117
Tersera Therapeutics LLC4$110
Ipsen Biopharmaceuticals, Inc5$109
Boehringer Ingelheim7$105
Octapharma USA, Inc.1$103
Regeneron Healthcare Solutions, Inc.4$101
Bristol Myers Squibb6$83
Takeda Pharmaceuticals U.S.A., Inc.4$68
Taiho Oncology, Inc.4$68
AMAG Pharmaceuticals, Inc.3$65
Helsinn Therapeutics (U.S.), Inc.5$63
Clovis Oncology, Inc.4$58
Global Blood Therapeutics, Inc.3$56
Dova Pharmaceuticals3$52
ADC Therapeutics America, Inc.3$50
EMD Serono, Inc.2$49
Kyowa Kirin, Inc.3$49
Verastem, Inc.3$48
Scilex Pharmaceuticals Inc.2$46
Servier Pharmaceuticals LLC2$46
Agios Pharmaceuticals, Inc.3$43
Blueprint Medicines Corporation2$34
Portola Pharmaceuticals, LLC2$32
G1 Therapeutics, Inc.2$31
Teva Pharmaceuticals USA, Inc.2$28
Pharmaessentia USA Corporation1$26
Myovant Sciences Inc.1$25
GSK1$23
CSL Behring1$22
Tesaro, Inc.1$20
AbbVie1$19
Puma Biotechnology, Inc.1$19
Foundation Medicine, Inc.1$18
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$18
Medtronic1$18
Coherus Oncology, Inc.1$18
Array Biopharma Inc1$17
Fortovia Therapeutics, Inc.1$17
Secura Bio, Inc.1$16
Novocure Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,969 in reported general payments places this provider in the 75th percentile of 157 hematology providers in New York.

See all hematology providers in New York →

Other hematology in Nyack

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →